- The effect of diphenyl-dimethyl-dicarboxylate on cyclosporine-A blood level in kidney transplants with chronic hepatitis
-
Kim YS, Kim DH, Kim DO, Lee BK, Kim KW, Park JN, Lee JC, Choi YS, Rim H
- KMID: 1038867
- Korean J Intern Med.
- 1997 Jan;12(1):67-69.
An adequate blood level of cyclosporine-A (CsA) is essential to keep graft function in kidney transplants. Due to a narrow therapeutic index and highly variable pharmacokinetic properties associated with CsA,... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
-
Kim H, Yi NJ, Lee J, Kim J, Moon MR, Jeong J, Lee JM, You TS, Suh SW, Park MS, Choi Y, Hong G, Lee HW, Lee KW, Suh KS
- KMID: 2069766
- Clin Mol Hepatol.
- 2014 Sep;20(3):291-299.
- doi: 10.3350/cmh.2014.20.3.291
BACKGROUND/AIMS: The dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
-
Suh SW, Lee KW, Jeong J, Kim H, Yi NJ, Suh KS
- KMID: 2470265
- J Korean Med Sci.
- 2016 Nov;31(11):1711-1716.
- doi: 10.3346/jkms.2016.31.11.1711
Despite the therapeutic equivalence between twice-daily and once-daily tacrolimus, patient safety after conversion is still a concern. We reviewed 218 liver transplantation (LT) patients who converted twice-daily to once-daily tacrolimus... -
- CITED
-
- Close
- SHARE
-
- Close
